| http://www.w3.org/ns/prov#value | - The patients who received NT or VEN in phase 1 continued on these medications, whereas the patients who had received PL were randomized to NT or VEN. The mask was maintained for whether the patient was treated with NT or VEN and whether patients received active medication or PL in phase 1.
|
